A study just published in the Green Journal (Journal of the American College of OB/GYN’s) was terminated early due to supposed safety concerns. This study was aimed at examining the efficacy and safety of a now well used protocol for abortion pill rescue (or APR). APR provides the possibility to save the unborn child if women change their mind after taking the first medication (mifepristone) of two that are involved with a medication abortion. After having three patients enrolled in the study require ambulance transfer — two of whom required emergency surgery with one also requiring a transfusion — the authors stopped the study due to “safety concerns”. However, a more thorough review of their data tells a different story.
First, what they fail to emphasize is the difference in the women who required transfer. Two out of the three patients were from the placebo group – not the group that received progesterone (the APR group)
Please also see the KRLA Forum article on Kentucky’s new law that requires abortionists to inform patients about the Abortion Reversal Pill.